HOUSE_OVERSIGHT_024656.jpg

1.46 MB

Extraction Summary

0
People
4
Organizations
1
Locations
0
Events
0
Relationships
3
Quotes

Document Information

Type: Investment report / market research
File Size: 1.46 MB
Summary

This document is page 20 of a Cannabis Investment Report dated December 2017, produced by Ackrell Capital, LLC. It details scientific information regarding cannabinoids, specifically contrasting THC and CBD, and provides a matrix of medical conditions (such as Cancer, ALS, and Glaucoma) alongside the specific cannabinoids used to treat them. The document bears a 'HOUSE_OVERSIGHT_024656' Bates stamp, indicating it was part of a document production for the House Oversight Committee, though the text itself contains no direct references to Jeffrey Epstein or his associates.

Organizations (4)

Locations (1)

Location Context

Key Quotes (3)

"Cannabinoids are compounds present in the cannabis plant that act on human cannabinoid receptors in cells in the nervous and immune systems."
Source
HOUSE_OVERSIGHT_024656.jpg
Quote #1
"Generally, the most abundant cannabinoid is THC, a psychoactive compound that causes a euphoric 'high,' and the second most abundant cannabinoid is cannabidiol, or CBD, which produces a relaxing physical effect without a psychoactive effect."
Source
HOUSE_OVERSIGHT_024656.jpg
Quote #2
"THC is the most abundant cannabinoid in cannabis and is understood to be the psychoactive compound in cannabis primarily responsible for the euphoric feeling of being 'high.'"
Source
HOUSE_OVERSIGHT_024656.jpg
Quote #3

Full Extracted Text

Complete text extracted from the document (2,092 characters)

ACKRELL
CAPITAL
Cannabis Investment Report | December 2017
■ Cannabinoids
Cannabinoids are compounds present in the cannabis plant that act on human cannabinoid receptors in cells in the nervous and immune systems. Scientists have identified more than 100 cannabinoids in the cannabis plant. Generally, the most abundant cannabinoid is THC, a psychoactive compound that causes a euphoric “high,” and the second most abundant cannabinoid is cannabidiol, or CBD, which produces a relaxing physical effect without a psychoactive effect. Consuming cannabinoids has been shown to have numerous medicinal benefits and therapeutic applications. The following table lists 20 common conditions for which medical cannabis use has been legalized under U.S. state laws and identifies 8 cannabinoids that are used or being studied to treat these conditions. A brief description of these cannabinoids follows the table.
Common Qualifying Medical Conditions and Potentially Therapeutic Cannabinoids
THC CBD CBC CBG CBGA CBN THCA CBDA
Alzheimer's disease • •
Amyotrophic lateral sclerosis (ALS) • • •
Anorexia •
Arthritis • •
Cachexia • •
Cancer • • • • • •
Chronic pain • • • • • •
Crohn's disease •
Epilepsy •
Glaucoma • • •
Hepatitis C • •
HIV/AIDS • •
Inflammation • • • • • •
Migraine • •
Multiple sclerosis •
Nausea • • •
Nervous system degeneration •
Parkinson's disease •
Post-traumatic stress disorder (PTSD) • •
Spasms • • • •
THC Tetrahydrocannabinol: THC refers to delta-9-tetrahydrocannabinol and certain chemical variants, including delta-8-tetrahydrocannabinol. THC is the most abundant cannabinoid in cannabis and is understood to be the psychoactive compound in cannabis primarily responsible for the euphoric feeling of being “high.” Both recreational and medicinal users often seek the psychoactive effects of THC and may prefer certain cannabis products based solely on the quality and level of THC. THC is believed to have wide-ranging medicinal benefits: analgesic, antianxiety, antibacterial, anticancer,
20
© 2017 Ackrell Capital, LLC | Member FINRA / SIPC
HOUSE_OVERSIGHT_024656

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document